Bal Pharma share news, announcements and annual reports
NSE: BALPHARMABSE: 524824Pharmaceuticals & BiotechnologySmall Cap
Bal Pharma Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Apr 1995 on BSE, May 2006 on NSE
Last close ₹84.61down ₹1.56 (1.81%)BSE ₹84.35
Share price at the NSE close on 29 Oct 2026. Previous close ₹86.17.
29 Oct: open ₹86.50, high ₹86.89, low ₹84.12
52-week range of traded prices to 29 Oct 2026
₹60.00Low, 30 Mar 2026₹124.60High, 10 Sep 2026
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹135 Cr2,779th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 18.69
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.64
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.42%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 9.0%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 9.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.94
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,181
Bal Pharma shareholder meetings
60 filed, newest first. Page 1 of 2.
Sep 2026
24 Sep · Meeting
Aug 2026
Jul 2026
Feb 2026
Jan 2026
8 Jan · Meeting
Sep 2025
25 Sep · Meeting
Jun 2025
30 Jun · Meeting
Sep 2024
25 Sep · Meeting
Dec 2023
Nov 2023
Sep 2023
Aug 2023
Jul 2023
20 Jul · Meeting
Sep 2022
19 Sep · Meeting
Aug 2022
Sep 2021
24 Sep · Meeting
Sep 2020
25 Sep · Meeting
Sep 2019
24 Sep · Meeting
23 Sep · Meeting
Aug 2019
Sep 2018
24 Sep · Meeting
Aug 2018
Sep 2017
22 Sep · Meeting
Aug 2017
Sep 2016
Aug 2016
Sep 2015
Aug 2015
14 Aug · Meeting
Register of Members and Share Transfer Books of the Company will remain closed from September 18, 2015 to September 22, 2015 (both days inclusive) to ascertain the entitlement of dividend and Annual General Meeting of the Company scheduled to be held on September 22, 2015.
Jun 2014
Sep 2013
Jul 2013
3 Jul · Meeting
Company has fixed Book Closure from September 16, 2013 to September 18, 2013 for the purpose of Payment of Dividend & Annual General Meeting (AGM) of the Company to be held on September 18, 2013.
Sep 2012
Aug 2012
13 Aug · Meeting
Board of Directors of the Company at its meeting held on August 13, 2012 has decided to close the Register of Members and Share Transfer Books of the Company from September 19, 2012 to September 21, 2012 (Both days inclusive) and convene the Annual General Meeting of the Company on September 21, 2012.
Sep 2011
23 Sep · Meeting
Annual General Meeting of the Company was held on September 21, 2011, as scheduled, Ordinary Resolutions approving the followings were passed at the meeting : (1) The audited Balance Sheet as at March 31, 2011 and Profit and Loss Account for the year ended on that date, together with the Directors' Report and Auditor's Report was adopted; (2) Mr. Arun Bhan was re-appointed as independent Director; (3) Dr.S.Prasanna was re-appointed as Executive Director; (4) Messrs TD Jain & DI Sakaria (erstwhile M/s Ostawal & Jain,) Auditors of the Company was reappointed and was authorized the Board of Directors to fix their remuneration.
Aug 2011
19 Aug · Meeting
Annual General Meeting of the Company will be held on September 21, 2011. The Register of Members and the Share Transfer Books will remain closed on September 21, 2011 for the purpose of the Annual General Meeting of the Company.
Sep 2010
27 Sep · Meeting
Annual General Meeting of the Company was held on September 27, 2010, as scheduled. Ordinary Resolutions approving the followings were passed at the meeting : (1) The audited Balance Sheet as at March 31, 2010 and Profit and Loss Account for the year ended on that date, together with the Directors' Report and Auditor's Report was adopted; (2) Mr. Shrenik Siroya was re-appointed as Director; (3) Dr.G.S.R Subba Rao was re-appointed as Director; (4) Messrs Ostawal & Jain, Auditors of the Company was reappointed and was authorized the Board of Directors to fix their remuneration.